[1] Article Title: Epidemiology of childhood neuromuscular diseases in two hospital districts in Finland
	•	Line(s): 1
	•	Section: Title Page
	•	Quote(s): “Epidemiology of childhood neuromuscular diseases in two hospital districts in Finland”

⸻

[2] Publication Year: 2025
	•	Line(s): ~100
	•	Section: Footer / Journal info
	•	Quote(s): “European Journal of Paediatric Neurology 55 (2025) 97–102”

⸻

[3] Region: Europe
	•	Line(s): 1
	•	Section: Title Page
	•	Quote(s): “…in two hospital districts in Finland”

⸻

[4] Country: Finland
	•	Line(s): 1
	•	Section: Title Page
	•	Quote(s): “…in two hospital districts in Finland”

⸻

[5] Coverage Area: Multi-regional
	•	Line(s): ~35–40
	•	Section: Methods – Study population
	•	Quote(s): “A retrospective registry-based study in the Pirkanmaa and Päijät-Häme Hospital Districts”

⸻

[6] Study Design: Retrospective, registry-based
	•	Line(s): ~35
	•	Section: Methods – Study population
	•	Quote(s): “A retrospective registry-based study in the Pirkanmaa and Päijät-Häme Hospital Districts…”

⸻

[7] Study Population: All children <17 years old with neuromuscular diseases in the study region
	•	Line(s): ~41–45
	•	Section: Methods – Procedures
	•	Quote(s): “…identify all under 17-year-old individuals with a neuromuscular disorder…”

⸻

[8] Population Characteristics: Age <17 years, 65,592 males among 128,358 children
	•	Line(s): ~37–40
	•	Section: Methods – Study population
	•	Quote(s): “The population of individuals under 17 years old was 128,358 (65,592 males)”

⸻

[9] Data Source Type: Hospital records
	•	Line(s): ~43
	•	Section: Methods – Procedures
	•	Quote(s): “We searched the patient records of both Tampere University Hospital… and Päijät-Häme Central Hospital…”

⸻

[10] Data Source Details: ICD-10 coded hospital records (G12, G60-G64, G70-G73)
	•	Line(s): ~43–45
	•	Section: Methods – Procedures
	•	Quote(s): “…for the following ICD-10 codes: G12, G60–G64 and G70–G73”

⸻

[11] Study Timeline Type: Retrospective
	•	Line(s): ~35
	•	Section: Methods – Study population
	•	Quote(s): “A retrospective registry-based study…”

⸻

[12] Number of Sites: 2
	•	Line(s): ~35
	•	Section: Methods – Study population
	•	Quote(s): “…in the Pirkanmaa and Päijät-Häme Hospital Districts”

⸻

[13] Study Start Year: 2008
	•	Line(s): ~41–45
	•	Section: Methods – Procedures
	•	Quote(s): “…individuals who received a neuromuscular diagnosis between 2008 and 2018”

⸻

[14] Study End Year: 2018
	•	Line(s): ~41–45
	•	Section: Methods – Procedures
	•	Quote(s): “…on December 31, 2018 and all under 17-year-old individuals who received a neuromuscular diagnosis between 2008 and 2018.”

⸻

[15] Main Ethnicity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Childhood neuromuscular diseases
	•	Line(s): Throughout
	•	Section: Title, Introduction, Results
	•	Quote(s): “…neuromuscular diseases in children…” and “The most prevalent myopathic disease was DMD… the most prevalent neurogenic disease was Charcot-Marie-Tooth…”

⸻

[18] Diagnosis Method: Clinical, EMG, nerve conduction, muscle biopsy, and genetic testing
	•	Line(s): ~50–55
	•	Section: Methods – Data collection
	•	Quote(s): “…clinical picture of a neuromuscular disease and/or abnormal findings on electromyography (EMG), nerve conduction studies, muscle biopsy or genetic testing.”

⸻

[19] Diagnosis Criteria Details: Diagnosis by pediatric neurologist; inclusion confirmed by review
	•	Line(s): ~48–50
	•	Section: Methods – Data collection
	•	Quote(s): “The inclusion criterion was a neuromuscular diagnosis established by the treating pediatric neurologist.”

⸻

[20] Disease Phase: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[21] Cohort Age Group: Pediatric
	•	Line(s): ~35–45
	•	Section: Methods – Study population
	•	Quote(s): “…under 17-year-old individuals…”

⸻

[22] Female % in Cohort: 48.9%
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[23] Consanguinity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR